Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEM2012MENOS65: BUMEL vs MEL-200 Conditioning in MM
NCT01916252Phase 3Completed
- Sponsor
- Fundación PETHEMA
- Start
- Sep 2013
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of busulfan in multiple myeloma (MM), sponsored by Fundación PETHEMA. Started Sep 2013; status: completed.
02
Drugs
busulfan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01916252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916252.